Table 3 Characteristics of high-risk patients according to each risk equation
REGICOR | UKPDS | ADVANCE | |
|---|---|---|---|
n = 312 | n = 691 | n = 737 | |
Age, years, mean (SD) | 64.1 (7.0) | 66 (6.6) | 68.1 (5.9) |
Gender, men, n (%) | 221 (70.8) | 469 (67.9) | 451 (61.2) |
Years since diabetes diagnosis, mean (SD) | 7.07 (5.4) | 12.9 (6.5) | 11.8 (7.1) |
Afroamericans/Afrocaribbeans, n (%) | 11 (3.5) | 9 (1.3) | 21 (2.8) |
Tobacco, n (%) | 118 (37.8) | 122 (17.7) | 86 (11.7) |
BMI, kg/m2, mean (SD) | 30.2 (4.7) | 29.9 (4.6) | 30.1 (4.9) |
Waist circumference, cm, mean (SD) | 100.2 (19.4) | 100.0 (16.7) | 101.0 (15.8) |
Pulse pressure, mmHg, mean (SD) | 59.2 (13.0) | 61.8 (13.7) | 63.9 (12.8) |
Glycated haemoglobin, %, mean (SD) | 7.4 (1.6) | 7.7 (1.6) | 7.4 (1.5) |
HDL, mg/dL, mean (SD) | 36.5 (8.1) | 45.3 (12.0) | 48.6 (12.8) |
Non-HDL cholesterol | 171.0 (42.5) | 149.7 (38.4) | 140.0 (37.4) |
UAER, mg/gr, mean (SD) | 37.3 (94.6) | 43.5 (161.7) | 55.1 (150.5) |
GFR, mil/min/1.73 m2, mean (SD) | 44 (96) | 43 (94) | 50 (101) |
Diabetic retinopathy, n (%) | 22 (7.1) | 98 (14.2) | 140 (19.0) |
Diabetes therapy, n (%) | |||
Diet | 57 (18.3) | 61 (8.8) | 73 (10.0) |
OA | 99 (31.7) | 185 (26.8) | 232 (31.7) |
OA + Insulin | 66 (21.2) | 152 (22.0) | 143 (19.5) |
Insulin | 18 (5.8) | 66 (9.6) | 78 (10.7) |
OA combined | 70 (22.4) | 221 (32.0) | 206 (28.1) |
Antihypertensive treatment, n (%) | 226 (72.4) | 491 (71.1) | 589 (79.9) |
Dyslipidaemia therapy, n (%) | 168 (53.8) | 375 (54.3) | 421 (57.1) |